Suven pharmaceuticals ltd NSE/BSE Share

Q: How to Buy Suven pharmaceuticals ltd Stock?

<div> Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders. <div> 1. Login to the Kuvera app or website and go to Invest section. </div> <div> 2. Select stocks and search for Suven pharmaceuticals ltd or scroll over to Suven pharmaceuticals ltd </div> <div> 3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction. </div> </div>

Q: What is the Share Price of Suven pharmaceuticals ltd?

<div>The share price of Suven pharmaceuticals ltd stocks is ₹1,217.30 as on 10/09/2024</div>

Q: What is the Market Cap of Suven pharmaceuticals ltd?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Suven pharmaceuticals ltd stock is ₹31,018.7 Cr on 10/09/2024.</div>

Q: In which sector / industry does Suven pharmaceuticals ltd operate?

<div>Suven pharmaceuticals ltd operates in Healthcare / Biotechnology.</div>

Q: What was the revenue of Suven pharmaceuticals ltd?

<div>The revenue of Suven pharmaceuticals ltd as of 2023 was ₹1,035.8 Cr</div>

Q: What is the PE ratio of Suven pharmaceuticals ltd?

<div>The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. P/E ratio of Suven pharmaceuticals ltd is 128.81 as on 10/09/2024.</div>

Q: What is the 52 week high price of Suven pharmaceuticals ltd?

<div> The 52 week high of Suven pharmaceuticals ltd stock is ₹1,257.10. </div>

Q: What is the 52 week low price of Suven pharmaceuticals ltd?

<div> The 52 week low of Suven pharmaceuticals ltd stock is ₹509.00. </div>

Q: Can fractional shares of Suven pharmaceuticals ltd be purchased?

<div>No, you cannot buy fractional shares of Suven pharmaceuticals ltd, or any listed Indian company as of now.</div>

Healthcare Biotechnology

₹1,217.30

+12.85

(7:11 am IST)

+1.1%

Loading chart

Price

₹1,217.30

Today’s high

₹1,257.10

Today’s low

₹1,216.00

52W high

₹1,257.10

52W low

₹509.00

135.2%

128.81

15.13

EPS (TTM)

11.80

Dividend yield

Market cap

₹31,018.7 Cr

Volume

12,100

Average volume

23,100

Insights

SUVENPHAR has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

SUVENPHAR price is above its 200 day moving average

SUVENPHAR PB is in the highest 10% across all stocks. The market is valuing it as a growth stock based on its book value.

SUVENPHAR PE is in the top end of its range over the past 2 years

SUVENPHAR PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

₹1,217.30

₹280.80

₹180.50

₹383.55

₹204.75

₹920.85

+1.1%

+3.8%

+2.6%

+1.7%

-0.7%

+3.0%

+135.2%

+110.0%

+96.6%

+43.9%

+26.3%

+9.7%

128.81

-61.44

820.45

29.06

-12.94

75.17

15.13

2.04

6.85

2.32

0.57

8.67

9.45

-4.57

0.22

13.20

-15.82

12.25

Large

Financials

Income statement

Balance sheet

Cash flow

Quarterly

Annual

As of 2023

Revenue

₹1,035.8 Cr

Net income

₹300.3 Cr

See stock holdings

Top institutional holders

DSP Investment Managers Private Limited

5.79%

UTI Asset Management Co Ltd

2.26%

Vanguard Group Inc

1.26%

Goldman Sachs Asset Management International

1.22%

Tata Asset Management Limited

1.15%

Top mutual fund holders

UTI Flexi Cap Fund

1.50%

DSP ELSS Tax Saver

1.24%

GS India Equity Portfolio

1.19%

DSP Healthcare Fund

1.14%

SBI Life-Midcap Fund

1.00%

About Suven Pharma

Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Company address

No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, Hyderabad, TG, 500081

Company URL

https://www.suvenpharm.com

Key executives

Name

Title

Age

Mr. Venkateswarlu Jasti

Director/Managing Director

72 yrs

Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju

Director/Managing Director

FAQs

How to Buy Suven pharmaceuticals ltd Stock?

What is the Share Price of Suven pharmaceuticals ltd?

What is the Market Cap of Suven pharmaceuticals ltd?

In which sector / industry does Suven pharmaceuticals ltd operate?

What was the revenue of Suven pharmaceuticals ltd?

What is the PE ratio of Suven pharmaceuticals ltd?

What is the 52 week high price of Suven pharmaceuticals ltd?

What is the 52 week low price of Suven pharmaceuticals ltd?

Can fractional shares of Suven pharmaceuticals ltd be purchased?